Dr. Giovanni Adami, a researcher studying bone loss in patients treated with low-dose glucocorticoids, discusses the potential benefits of low doses in inflammatory diseases and the limitations of measuring bone mineral density in glucocorticoid-induced osteoporosis. The podcast also explores the findings of a study on osteoporosis therapy for rheumatic disease patients receiving lower glucocorticoid doses, suggesting a change in practice compared to current guidelines.